CDH1 and cancer: In this study, we found that sunitinib treatment led to the formation of drug-resistant cell colonies with high levels of E-cadherin, which maintained cell‒cell adhesion; high levels of c-Met phosphorylation, which increases invasiveness; and high levels of Oct4, which regulates cancer stemness.